NCT02443012View on ClinicalTrials.gov

Topical Nepafenac as Supplement for Diabetic Macular Edema

PHASE4CompletedINTERVENTIONAL
Enrollment

47

Participants

Timeline

Start Date

March 31, 2013

Primary Completion Date

August 31, 2014

Study Completion Date

August 31, 2014

Conditions
Diabetic Macular Edema
Interventions
DRUG

Topical Gutt Nepafenac 0.1%

Topical Nepafenac as an adjunct to focal/grid laser

PROCEDURE

Laser

Grid/Focal Laser Photocoagulation

Trial Locations (2)

16150

Hospital Universiti Sains Malaysia, Kubang Kerian

68000

Hospital Selayang, Batu Caves

All Listed Sponsors
lead

Universiti Sains Malaysia

OTHER

NCT02443012 - Topical Nepafenac as Supplement for Diabetic Macular Edema | Biotech Hunter | Biotech Hunter